Clinical Trials Directory

Trials / Completed

CompletedNCT02744378

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus- A Double-blinded Randomized Clinical Trial in Sri Lanka

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
68 (actual)
Sponsor
University of Peradeniya · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This clinical study is carried out to assess the efficacy of Tacrolimus and Clobetasol in symptomatic Oral Lichen Planus.

Conditions

Interventions

TypeNameDescription
DRUGTacrolimus 0.1%This group was randomly allocated to receive topical Tacrolimus 0.1% for 3 consecutive weeks
DRUGClobetasol 0.05%This group was randomly allocated to receive topical Clobetasol 0.05% for 3 consecutive weeks

Timeline

Start date
2014-06-01
Primary completion
2015-07-01
Completion
2015-12-01
First posted
2016-04-20
Last updated
2016-04-20

Source: ClinicalTrials.gov record NCT02744378. Inclusion in this directory is not an endorsement.

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus (NCT02744378) · Clinical Trials Directory